Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd928b5c64cf0e30e2925ad47ed996b4 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0021 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
filingDate |
2014-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d6d816a30004b8fa3a33af11edb3792 |
publicationDate |
2016-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20160020411-A |
titleOfInvention |
Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias |
abstract |
The present invention provides a new use of lanthanide hydrochloride for the continuous reduction of heart rate during the treatment period of lanthanoid hydrochloride in the treatment of a person suffering from tachycardia, tachyarrhythmia or elevated blood pressure, wherein the lanthanide hydrochloride is at least Kg / min, more specifically at least 10 g / kg / min for a period of 2 hours, and the patient's heart rate and / or blood pressure is administered in comparison with the heart rate and / And the overshoot effect does not occur after the end of the administration. |
priorityDate |
2013-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |